S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.21%) $0.928
USD/NOK
(0.17%) $10.86
USD/GBP
(0.00%) $0.792
USD/RUB
(-0.29%) $92.31

Realtime updates for Taro Pharmaceutical [TARO]

Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated28 Mar 2024 @ 16:00

0.19% $ 42.34

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally...

Stats
Today's Volume 31 473.00
Average Volume 52 936.00
Market Cap 1.59B
EPS $0 ( 2024-01-25 )
Next earnings date ( $0.310 ) 2024-05-28
Last Dividend $12.81 ( 2018-12-10 )
Next Dividend $0 ( N/A )
P/E 34.70
ATR14 $0.0330 (0.08%)
Insider Trading
Date Person Action Amount type
2011-01-18 Sun Pharmaceutical Industries Ltd Buy 712 500 Restricted Shares
2011-01-18 Sun Pharmaceutical Industries Ltd Buy 712 500 Restricted Shares
2011-01-18 Sun Pharmaceutical Industries Ltd Sell 712 500 Warrant (right to buy)
2010-11-04 Sun Pharmaceutical Industries Ltd Buy 5 159 765 Ordinary Shares
2010-11-01 Franklin Resources Inc Sell 5 159 765 Ordinary Shares
INSIDER POWER
0.00
Last 84 transactions
Buy: 16 575 249 | Sell: 25 681 902

Volume Correlation

Long: 0.09 (neutral)
Short: 0.82 (strong)
Signal:(64.841) Same movement expected

Taro Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Taro Pharmaceutical Correlation - Currency/Commodity

The country flag -0.09
( neutral )
The country flag -0.10
( neutral )
The country flag 0.00
( neutral )
The country flag -0.27
( neutral )
The country flag 0.00
( neutral )
The country flag -0.03
( neutral )

Taro Pharmaceutical Financials

Annual 2023
Revenue: $572.95M
Gross Profit: $268.32M (46.83 %)
EPS: $0.680
Q4 2023
Revenue: $146.59M
Gross Profit: $75.71M (51.65 %)
EPS: $0.180
Q3 2023
Revenue: $139.20M
Gross Profit: $64.05M (46.01 %)
EPS: $0.190
Q2 2023
Revenue: $130.50M
Gross Profit: $46.96M (35.99 %)
EPS: $-0.0748

Financial Reports:

No articles found.

Taro Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Taro Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.86 - average (62.51%) | Divividend Growth Potential Score: 2.19 - No dividend growth expected in the near future
Information
First Dividend $12.81 2018-12-10
Last Dividend $12.81 2018-12-10
Next Dividend $0 N/A
Payout Date 2018-12-28
Next Payout Date N/A
# dividends 1 --
Total Paid Out $12.81 --
Avg. Dividend % Per Year 0.00% --
Score 1.22 --
Div. Sustainability Score 5.86
Div.Growth Potential Score 2.19
Div. Directional Score 4.03 --
Next Divdend (Est)
(2024-03-29)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.22
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2018 $12.81 12.40%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend Royal 2023-11-15 Monthly 14 9.37% 8.50
NCZ Dividend Royal 2024-02-09 Monthly 22 7.79% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07481.5008.5010.00[0 - 0.5]
returnOnAssetsTTM0.02111.2009.3010.00[0 - 0.3]
returnOnEquityTTM0.02611.500-0.821-1.231[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.600.80010.008.00[1 - 3]
quickRatioTTM3.030.80010.008.00[0.8 - 2.5]
cashRatioTTM1.0221.5005.438.15[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM-2.551.000-2.05-2.05[3 - 30]
operatingCashFlowPerShareTTM3.802.008.7310.00[0 - 30]
freeCashFlowPerShareTTM2.292.008.8610.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.4801.0005.335.33[0.2 - 0.8]
operatingProfitMarginTTM0.03601.000-1.280-1.280[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.2820.800-1.451-1.161[0.5 - 2]
Total Score5.86

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM34.821.0006.580[1 - 100]
returnOnEquityTTM0.02612.50-0.528-1.231[0.1 - 1.5]
freeCashFlowPerShareTTM2.292.009.2410.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM3.802.008.7310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.7681.500-8.450[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2341.0006.650[0.1 - 0.5]
Total Score2.19

Taro Pharmaceutical

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators